Analyst Ratings for BioMarin Pharmaceutical Inc. (BMRN)
BMRN Rating Summary
BMRN Price Target Summary
- Highest: $120.00 (Evercore ISI)
- Lowest: $50.00 (H.C. Wainwright)
- Average: $90.22
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$90.22 (+51.4%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
Avg. $ Target:
$90.22 (+51.4%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/20/2026 | JPMorgan | Jessica Fye | New Coverage | Overweight (N/A) |
80.00 (N/A) |
49.67 (59.59) |
19.97% | Details |
| 5/18/2026 | Citi » Updated 7/16/2026 |
Eric Joseph | New Coverage | Buy (N/A) |
76.00 (75.00) |
51.81 (59.59) |
15.02% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
